Novo Nordisk
NVO
#86
Rank
S$259.69 B
Marketcap
S$58.58
Share price
-2.72%
Change (1 day)
-29.85%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): S$32.06 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$51.37 Billion. In 2025 the company made an earning of S$26.81 Billion, an increase over its 2024 earnings that were of S$25.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$32.06 B19.57%
2025 S$26.81 B6.28%
2024 S$25.22 B28.01%
2023 S$19.70 B57.81%
2022 S$12.48 B5.24%
2021 S$11.86 B12.38%
2020 S$10.55 B13.11%
2019 S$9.33 B-3.45%
2018 S$9.66 B1.88%
2017 S$9.49 B4.3%
2016 S$9.09 B10.32%
2015 S$8.24 B7.47%
2014 S$7.67 B3.4%
2013 S$7.42 B19.09%
2012 S$6.23 B15.58%
2011 S$5.39 B16.58%
2010 S$4.62 B25.66%
2009 S$3.68 B10.68%
2008 S$3.32 B55.82%
2007 S$2.13 B7.02%
2006 S$1.99 B19.05%
2005 S$1.67 B10.55%
2004 S$1.51 B
2002 S$1.05 B-14.39%
2001 S$1.23 B-52.82%
2000 S$2.61 B250%
1999 S$0.74 B31.21%
1998 S$0.56 B34.31%
1997 S$0.42 B11.46%
1996 S$0.37 B9.03%
1995 S$0.34 B-3.15%
1994 S$0.35 B-0.67%
1993 S$0.36 B45.38%
1992 S$0.24 B-13.81%
1991 S$0.28 B37.12%
1990 S$0.21 B-0.79%
1989 S$0.21 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.54 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.81 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.79 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$12.27 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA